Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
The invention relates to novel combinations based on anticholinergics, β2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Europäisches Patentamt - (2018) vom: 28. Sept. Zur Gesamtaufnahme - year:2018 |
---|
Sprache: |
Unbestimmt |
---|
Beteiligte Personen: |
MAUS JOACHIM [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2018-09-28, Last updated: 2021-03-11 |
---|
Patentnummer: |
US2012076739 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA007200390 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA007200390 | ||
003 | DE-627 | ||
005 | 20230504080402.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210531s2018 xx |||||o 00| ||und c | ||
035 | |a (DE-627)EPA007200390 | ||
035 | |a (EPA)US2012076739 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a und | ||
100 | 0 | |a MAUS JOACHIM |e verfasserin |4 aut | |
245 | 1 | 0 | |a Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2018-09-28, Last updated: 2021-03-11 | ||
520 | |a The invention relates to novel combinations based on anticholinergics, β2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases. | ||
650 | 4 | |a A61K | |
650 | 4 | |a che | |
650 | 4 | |a A61P | |
650 | 4 | |a 615 | |
700 | 0 | |a KASTRUP HORST |e verfasserin |4 aut | |
700 | 0 | |a SZELENYI ISTVAN |e verfasserin |4 aut | |
700 | 0 | |a CNOTA PETER JUERGEN |e verfasserin |4 aut | |
700 | 0 | |a BAUHOFER ARTUR |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2018) vom: 28. Sept. |
773 | 1 | 8 | |g year:2018 |g day:28 |g month:09 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/searchResults?DB=EPODOC&locale=en_EP&query=US2012076739A1 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2018 |b 28 |c 09 |
951 | |a AR | ||
952 | |j 2018 |b 28 |c 09 |